Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Oncternal Therapeutics, Inc. has filed 1,606 SEC EDGAR filings since 21 Aug 2003

SEC filing history

Showing 426-450 of 1,000 matching filings.

Per page
25
Current page
18
4

FORM 4 -

Filing date
02 Oct 2018
Reporting date
01 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

8-K

Filing date
21 Sep 2018
Reporting date
21 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

8-K

Filing date
14 Aug 2018
Reporting date
14 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A -

Filing date
17 Jul 2018
Reporting date
13 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
17 Jul 2018
Reporting date
13 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
03 Jul 2018
Reporting date
02 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
03 Jul 2018
Reporting date
02 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
03 Jul 2018
Reporting date
02 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
26 Jun 2018
Reporting date
26 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
22 Jun 2018
Reporting date
20 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
22 Jun 2018
Reporting date
20 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-79588

SCHEDULE 13G

Filing date
29 May 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

8-K

Filing date
18 May 2018
Reporting date
18 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

8-K

Filing date
16 May 2018
Reporting date
16 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

8-K

Filing date
15 May 2018
Reporting date
15 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
11 May 2018
Reporting date
10 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
11 May 2018
Reporting date
10 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
11 May 2018
Reporting date
10 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
11 May 2018
Reporting date
10 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

8-K

Filing date
09 Apr 2018
Reporting date
09 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
03 Apr 2018
Reporting date
02 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
03 Apr 2018
Reporting date
02 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
03 Apr 2018
Reporting date
02 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .